Quantum Pharmaceuticals and MOLECMO Nanobiotechnologies announce collaboration.

Moscow, Russia (August, 13 2007) -Quantum Pharmaceuticals announced today a collaboration with MOLECMO Nanobiotechnologies, a drug discovery company.
The collaboration is aimed at application of Quantum Pharmaceuticals' industry leading technology to anti-viral drug discovery project led by MOLECMO. The financial terms of the agreement were not disclosed.
About Quantum Pharmaceuticals.
Quantum Pharmaceuticals is a drug discovery company based in Moscow, Russia specializing in small molecule screening and design through the use of its proprietary technology platform.
About MOLECMO.
MOLECMO is an antiviral drug discovery company based in Cambridge, Massachusetts in the heart of the biotechnology circle, proximal to world class research institutes like Harvard and MIT, famed Boston Hospitals and leading Pharmaceutical firms.